...
首页> 外文期刊>Iranian Journal of Pharmaceutical Research >Design and Synthesis of Novel Triazole-based Peptide Analogues as Anticancer Agents
【24h】

Design and Synthesis of Novel Triazole-based Peptide Analogues as Anticancer Agents

机译:新型三唑基肽类似物作为抗癌药的设计与合成

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cancer disease is a great concern in the worldwide public health and current treatments do not give satisfactory results, so, developing novel therapeutic agents to combat cancer is highly demanded. Nowadays, anticancer peptides (ACPs) are becoming promising anticancer drug candidates. This is due to several advantages inherited in peptide molecules, such as being usually with small size, high activity, low immunogenicity, good biocompatibility, diversity of sequence, and more modification sites for functionalization. To get benefit of these merits, in this work, we synthesized a new series of triazole- based analogues with peptide scaffold by employing click chemistry and evaluated their anticancer activities against breast, colon cancer cell lines as well as fibroblast cells using MTT assay. Our results suggest that peptide scaffolds containing 1H-1, 2, 3-triazole ring group are toxic against colon and breast cancer cells viability, and this effect was more pronounced on MDA-MB-231 cells compared with MCF-7 breast cells. As a conclusion, these designed peptide analogues may be good and safe candidates as future anticancer agents.
机译:癌症疾病是世界范围内公共卫生中非常关注的问题,并且当前的治疗方法未获得令人满意的结果,因此,迫切需要开发新的治疗剂来对抗癌症。如今,抗癌肽(ACP)成为有前途的抗癌药物候选物。这归因于肽分子中继承的几个优点,例如通常具有小尺寸,高活性,低免疫原性,良好的生物相容性,序列多样性以及更多的功能化修饰位点。为了从这些优点中受益,在这项工作中,我们通过点击化学合成了一系列新的基于三唑的类似物与肽支架,并使用MTT法评估了它们对乳腺癌,结肠癌细胞系和成纤维细胞的抗癌活性。我们的结果表明,含有1H-1、2、3-三唑环基团的肽支架对结肠和乳腺癌细胞具有毒性,与MCF-7乳腺癌细胞相比,这种作用在MDA-MB-231细胞上更为明显。结论是,这些设计的肽类似物可能是未来抗癌药的良好且安全的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号